News Focus
News Focus
Followers 202
Posts 9949
Boards Moderated 7
Alias Born 10/02/2010

Re: Sage7243 post# 5247

Wednesday, 05/31/2017 11:38:23 PM

Wednesday, May 31, 2017 11:38:23 PM

Post# of 21373
Hey there Sage,

I know active traders see dozens of reverse mergers hit the BOB every week.

AEPP is different than all of the ones I have seen over the years.

Most OTC reverse mergers are heavily diluted with large share structures.

AEPP is unique because of the small float and O/S, which gives us the small market cap that investors like to see.

Most OTC reverse mergers don’t have accredited investors already onboard.

Oncolix is unique because they have a proven history of being able to raise investment capital as a private company.

Most OTC reverse mergers don’t include companies with a significant worldwide patent portfolio like Oncolix has.

For me, AEPP is an OTC hat trick for investors that can recognize the difference between the risk/reward ratio of AEPP vs. every other reverse merger currently in play.

10,000 shares of AEPP @ .08 = $800. As with any other OTC play, you could lose it all. Thats the risk.

An Oncolix/AEPP with a $93 market cap, post merger, is possible with everything that is currently known.

A $93M market cap would give AEPP a PPS of $1.00.

10,000 shares @ $1.00 = $10,000.

Potential risk = $800 for a potential reward of $10,000.

I like those odds.

IMO and FWIW.

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today